Concord Medical Co., Ltd. (TPEX:6518)

Market Cap	910.00M +4.6%
Revenue (ttm)	964.35M +4.9%
Net Income	67.36M +16.4%
EPS	2.01 +16.3%
Shares Out	33.33M
PE Ratio	13.58
Forward PE	n/a
Dividend	1.10 (4.03%)
Ex-Dividend Date	Apr 10, 2026

Volume	31,200
Average Volume	13,420
Open	26.40
Previous Close	27.35
Day's Range	26.20 - 27.35
52-Week Range	22.80 - 28.40
Beta	0.34
RSI	57.99
Earnings Date	Mar 13, 2026

About Concord Medical

Concord Medical Co., Ltd. provides hospital management support services primarily in Taiwan. The company offers medical management services that include medical training and nursing staffing and assisting on medical management; and procurement services for instruments and equipment, drugs, medical materials and consumables, testing equipment, and reagents and consumables, as well as develops its own brand for medical aesthetic skincare products, health foods, and topical Chinese medicine products. It is also involved in the medical equipment pl...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2009
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6518

Financial Performance

In 2024, Concord Medical's revenue was 889.85 million, an increase of 6.80% compared to the previous year's 833.20 million. Earnings were 49.57 million, an increase of 15.97%.